Novo Nordisk's Retatrutide Australia: A New Solution for Obesity Management ?
Australia is a growing epidemic of overweight , and this arrival of Retatrutide offers a novel avenue for intervention. This innovative medication, developed by Novo Nordisk , combines the functions of two hormones – GLP-1 and GIP – in order to impact food intake and promote feelings of fullness